| MEDIF Stock | | | USD 0.05 0 2.22% |
President
Mr. Keith Strachan serves as President and Director of the Company Since ctober 1, 2018. Previous serves as VP Business Development, the Company . since 2019.
| Tenure | 5 years |
| Phone | 705 719 7425 |
| Web | https://www.medipharmlabs.com |
Medipharm Labs Management Efficiency
The company has return on total asset
(ROA) of
(0.236) % which means that it has lost $0.236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.5658) %, meaning that it generated substantial loss on money invested by shareholders. Medipharm Labs' management efficiency ratios could be used to measure how well Medipharm Labs manages its routine affairs as well as how well it operates its assets and liabilities.
Medipharm Labs Corp has accumulated 1.44
M in total debt with debt to equity ratio
(D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. Medipharm Labs Corp has a current ratio of 5.13, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medipharm Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Medipharm Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medipharm Labs Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medipharm to invest in growth at high rates of return. When we think about Medipharm Labs' use of debt, we should always consider it together with cash and equity.
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States. Medipharm Labs Corp [MEDIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Medipharm Labs Corp Leadership Team
Elected by the shareholders, the Medipharm Labs' board of directors comprises two types of representatives: Medipharm Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medipharm. The board's role is to monitor Medipharm Labs' management team and ensure that shareholders' interests are well served. Medipharm Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medipharm Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Medipharm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Medipharm Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.